Hims & Hers Health Inc. (HIMS) Q4 2025 (USD): Adj. EBITDA 66.3mln (exp. 61.8mln), Revenue 618mln (exp. 619mln), Q1 adj. EBITDA view 35-55mln (exp. 81.7mln), revenue view 600-625mln (exp 653mln).
Importance
Level 1
FY guidance
- Adj. EBITDA 300-375mln (exp. 366.6mln).
- Revenue 2.7-2.9bln (exp. 2.74bln).
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#FOREX#METALS#ASIAN SESSION#US SESSION#METALS & MINING#DXY#US EQUITIES